OBSEGONE Trademark
Trademark Overview
On Wednesday, April 23, 2025, a trademark application was filed for OBSEGONE with the United States Patent and Trademark Office. The USPTO has given the OBSEGONE trademark a serial number of 79435559. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 14, 2026. This trademark is owned by SHANGHAI INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.. The OBSEGONE trademark is filed in the Pharmaceutical Products category with the following description:
Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; herbal tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmac...
General Information
| Serial Number | 79435559 |
| Word Mark | OBSEGONE |
| Filing Date | Wednesday, April 23, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, July 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 4, 2026 |
Trademark Statements
| Goods and Services | Drugs for medical purposes, namely, medical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparation for treating alcoholic fatty liver; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of alzheimer's disease; herbal tea for medical purposes; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); slimming pills; appetite suppressant pills; pharmaceutical preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); cardiovascular pharmaceuticals for medical use; medicines for human purposes, namely, medicinal preparations for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); appetite suppressants for medical purposes; biological preparations for medical purposes for the treatment of diabetes, obesity, Alzheimer's disease, metabolic dysfunction-associated steatohepatitis (MASH), and metabolic dysfunction-associated steatotic liver disease (MASLD); medical preparations for slimming purposes; medical preparation for treating diabetes; slimming tea for medical purposes; antidiabetic pharmaceuticals; antidiabetic preparation; cardiovascular pharmaceutical preparations; lipotropic factor preparation; dietetic supplements adapted for medical use; diabetic bread adapted for medical use; dietetic beverages featuring fruit juices with pulp adapted for medical purposes, for use by diabetic patients |
| Description of Mark | The mark consists of the wording "OBSEGONE" in stylized font. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | SHANGHAI INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
Trademark Events
| Event Date | Event Description |
| Thursday, October 30, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, November 1, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 1, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, November 2, 2025 | ASSIGNED TO EXAMINER |
| Friday, November 7, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, November 8, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 27, 2025 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, December 17, 2025 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 17, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 1, 2026 | REFUSAL PROCESSED BY IB |
| Wednesday, June 3, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 3, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 3, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 2, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, July 2, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 2, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, July 2, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 2, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
